These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4834542)

  • 21. Dissociation between free and bound phenytoin levels in presence of valproate sodium.
    Rodin EA; DeSousa G; Haidukewych D; Lodhi R; Berchou RC
    Arch Neurol; 1981 Apr; 38(4):240-2. PubMed ID: 6783018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.
    Cook CE; Amerson E; Poole WK; Lesser P; O'Tuama L
    Clin Pharmacol Ther; 1975 Dec; 18(6):742-7. PubMed ID: 1204279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of phenytoin associated gingival enlargement--a 15-month longitudinal study.
    Pihlstrom BL; Carlson JF; Smith QT; Bastien SA; Keenan KM
    J Periodontol; 1980 Jun; 51(6):311-7. PubMed ID: 6930469
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of salicylate on the pharmacokinetics of phenytoin.
    Olanow CW; Finn AL; Prussak C
    Neurology; 1981 Mar; 31(3):341-2. PubMed ID: 7193826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saliva monitoring of anticonvulsants.
    Reynolds F; Knott C
    J Clin Chem Clin Biochem; 1989 Apr; 27(4):226-7. PubMed ID: 2738523
    [No Abstract]   [Full Text] [Related]  

  • 26. Salivary phenytoin concentrations.
    Mitchell W; Greenwood RS
    J Pediatr; 1981 Dec; 99(6):1000. PubMed ID: 7310575
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW
    Clin Pharmacol Ther; 1980 Feb; 27(2):170-8. PubMed ID: 7353335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva phenobarbital and phenytoin concentrations in epileptic adolescents.
    Friedman IM; Litt IF; Henson R; Holtzman D; Halverson D
    J Pediatr; 1981 Apr; 98(4):645-7. PubMed ID: 7205497
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
    Ball DE; McLaughlin WS; Seymour RA; Kamali F
    J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved method for preparation of samples for the simultaneous assay of some antiepileptic drugs by gas-liquid chromatography.
    Schweizer K; Wick H; Brechbühler T
    Clin Chim Acta; 1978 Dec; 90(3):203-8. PubMed ID: 31991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compliance with anticonvulsant therapy in a hospital clinic and in the community.
    Mucklow JC; Dollery CT
    Br J Clin Pharmacol; 1978 Jul; 6(1):75-9. PubMed ID: 666949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
    Sobaniec W
    Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary concentrations of antiepileptic drugs.
    Lancet; 1976 Sep; 2(7986):639-40. PubMed ID: 61381
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug formulation and salivary phenytoin measurements.
    Ayers GJ; Burnett D
    Lancet; 1977 Mar; 1(8012):656. PubMed ID: 66462
    [No Abstract]   [Full Text] [Related]  

  • 35. Diphenylhydantoin excretion in the semen of treated epileptics.
    Cohn DF; Homonnai ZT; Paz GP
    Isr J Med Sci; 1982 Apr; 18(4):509-11. PubMed ID: 7085253
    [No Abstract]   [Full Text] [Related]  

  • 36. [Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin].
    Mascher J; Bernhardt W
    Z Neurol; 1973 May; 204(3):179-92. PubMed ID: 4123516
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous quantitation of salivary carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbitone by high-performance liquid chromatography.
    Herkes GK; McKinnon GE; Eadie MJ
    J Chromatogr; 1989 Nov; 496(1):147-54. PubMed ID: 2592508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures.
    Lund L
    Arch Neurol; 1974 Nov; 31(5):289-94. PubMed ID: 4212949
    [No Abstract]   [Full Text] [Related]  

  • 39. Citrate and salivary drug measurement.
    Knott C; Reynolds F
    Lancet; 1987 Jan; 1(8524):97. PubMed ID: 2879190
    [No Abstract]   [Full Text] [Related]  

  • 40. Salivary drug measurement: a cautionary tale.
    Paton RD; Logan RW
    Lancet; 1986 Dec; 2(8519):1340. PubMed ID: 2878213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.